MDCK-MRP2 - Dkfz

190
Forschungsschwerpunkt C
Krebsrisikofaktoren und Krebsprävention
[9] Hoffmann W.* Latza U.*, Ahrens W.*, Greiser K.H.*, Kroke
A.*, Nieters A., Schulze M.B.*, Steiner M.*, Terschuren C.*,
Wjst M.* Biological markers in epidemiology: concepts, applications,
perspectives (partI). Gesundheitswesen (2002) 64(2): 99-
107.
[10] Hoffmann W.* Latza U.*, Ahrens W.*, Greiser K.H.*, Kroke
A.*, Nieters A., Schulze M.B.*, Steiner M.*, Terschuren C.*,
Wjst M.* Biological markers in epidemiology: concepts, applications,
perspectives (partII). Gesundheitswesen (2002) 64(3):
145-52.
[11] Kjaerheim K.*, Boffetta P., Hansen J.*, Cherrie J.*, Chang-
Claude J, Eilber U., Ferro G.*, Guldner K.*, Olsen JH.*, Plato
N.*, Proud L.*, Saracci R.*, Westerholm P.*, Andersen A. Lung
Cancer Among Rock and Slag Wool Production Workers Epidemiology
(2002) 13(4): 445-453.
[12] Knorr-Held L.*, Rasser G.*, Becker N. Disease mapping of
stage-specific cancer incidence data. Biometrics (2002) 58: 492 -
501.
[13] Kropp S., Chang-Claude J. Active and passive smoking and
risk of breast cancer by age 50 among German women. Am J
Epidemiol, (2002) 156(7):616-26.
[14] Kynast-Wolf G.*, Becker N., Kroke A.*, Brandstetter B.*,
Wahrendorf J.*, Boeing H.* Linear regression calibration - theoretical
framework and empirical results in EPIC Germany. Ann.
Nutr. Metab. (2002) 45: 2 - 8.
[15] Linseisen J., Becker N. Primäre Krebsprävention mit
Ernährung – Empfehlungen und präventives Potential. Dt Med
Woschr. 2002; 127: 425-426.
[16] Meijers-Heijboer H.*, van den Ouweland A.*, Klijn J.*,
Wasielewski M.*, de Snoo A.*, Oldenburg R.*, Hollestelle A.*,
Houben M.*, Crepin E.* , van Veghel-Plandsoen M.*, Elstrodt
F.*, van Duijn C.*, Bartels C.*, Meijers C.*, Schutte M.*,
McGuffog L.*, Thompson D.*, Easton DF.*, Sodha N.*, Seal S.*,
Barfoot R.*, Mangion J.*, Chang-Claude J, Eccles D.*, Eeles
R.*, Evans DG.*, Houlston R.*, Murday V.*, Narod S.*, Peretz
T.*, Peto J.*, Phelan C.*, Zhang HX.*, Szabo C.*, Devilee P.*,
Goldgar D.*, Futreal PA.*, Nathanson KL.*, Weber BL.*,
Rahman N.*, Stratton MR.* Low-penetrance susceptibility to
breast cancer due to CHEK2*1100delC in noncarriers of BRCA1
or BRCA2 mutations Nature Genetics (2002) 31: 55-59.
[17] Miller A.B. Editorial comment. The (in)efficiency of cervical
screening in Europe. Eur J. Cancer (2002) 38: 321-326.
[18] Miller A.B., To T.*, Baines C.J.*, Wall C.* The Canadian National
Breast Screening Study-1: Breast cancer mortality after 11
to 16 years of follow-up. A randomized screening trial of mammography
in women age 40 to 49 years. Ann Intern Med (2002)
137: 305-312.
[19] Miller A.B. Der naturliche Verlauf einer Infektion der Cervix
uteri mit humanen Papillomaviren. Frauenarzt (2002) 43:686-
690.
[20] Nagel G., Röhrig B.*, Hoyer H.*, Füller J.*, Katenkamp D.*
Bevölkerungsbezogene Studie über die Anwendung adjuvanter
Strahlentherapie bei Patientinnen mit Mammakarzinom.
Strahlenther Onkol. (2002) 11: 589-596.
[21] Nieters A., Becker N., Linseisen J. Polymorphisms in candidate
obesity genes and their interaction with dietary intake of n-
6 polyunsaturated fatty acids affect obesity risk in a sub-sample
of the EPIC-Heidelberg cohort. European J. Nutrition Oct. (2002)
41(5): 210-221.
[22] Quian D.*, and Beckmann L. Minimum-recombinant haplotyping
in pedigrees. Am J Hum Genet. (2002) 70(6):1434-45.
[23] Radtke J.*, Linseisen J., Wolfram G.*: Plasma concentrations
of selected flavonoids as biomarkers of intake. Eur J Nutr
2002, 41: 203-209.
[24] Razum O.* & Rohrmann S. Der Healthy-migrant-Effekt:
Bedeutung von Auswahlprozessen bei der Migration und Lateentry-Bias.
Gesundheitswesen (2002) 64(2): 82-8.
[25] Rohrmann S., Becker N. Development of a short questionnaire
to assess the dietary intake of heterocyclic aromatic
amines. Public Health Nutrition (2002) 5: 699-705.
Abteilung C020
Klinische Epidemiologie
DKFZ 2004: Wissenschaftlicher Ergebnisbericht 2002 - 2003
[26] Rohrmann S., Linseisen J., Becker N., et al. Cooking of Meat
and Fish in Europe – Results from the European Prospective Investigation
into Cancer and Nutrition (EPIC). European Journal
of Clinical Nutrition (2002): 56:1216-30.
[27] Smith-Warner S.A.*, Ritz J.*, Hunter D.J.*, Albanes D.*,
Beeson L.*, Van den Brandt, Colditz G.*, Folsom A.R.*, Fraser
G.E.*, Freudenheim J.L.*, Giovanucci E.*, Goldbloom A.*, Graham
S.*, Kushi L.E.*, Miller A.B., Willett W.C.* Dietary fat and
risk of lung cancer in a pooled analysis of prospective studies.
Cancer Epidemiology, Biomarkers and Prevention (2002) 11:987-
992.
[28] Terry P.D.*, Miller A.B., Rohan T.E.* Cigarette smoking and
breast cancer risk: A long latency period? Int J Cancer (2002)
100:723-728.
[29] Terry P.D.*, Miller A.B., Rohan T.E.* Obesity and colorectal
cancer risk in women. Gut (2002) 51:191-194.
[30] Thompson D*, Szabo C.I.*, Mangion J.*, Oldenburg R.A.*,
Odefrey F.*, Seal S.*, Barfoot R.*, Kroeze-Jansema K.*, Teare
D.*, Rahman N.*, Renard H.*, Mann G.*, Hopper J.L.*, Buys
S.S.*, Andrulis I.L.*, Senie R.*, Daly M.B.*, West D.*,
Ostrander E.A.*, Offit K*, Peretz T.*, Osorio A.*, Benitez J.*,
Nathanson K.L.*, Sinilnikova O.M.*, Olah E.*, Bignon Y.J.*, Ruiz
P.*, Badzioch M.D.*, Vasen H.F.*, Futreal A.P.*, Phelan C.M.*,
Narod S.A.*, Lynch H.A.T.*, Ponder B.A.*, Eeles R.A.*, Meijers-
Heijboer H.*, Stoppa-Lyonnet D.*, Couch F.J.*, Eccles D.M.*,
Evans D.G.*, Chang-Claude J., Lenoir G.*, Weber B.L.*, Devilee
P.*, Easton D.F.*, Goldgar D.E.*, Stratton M.R.*. Evaluation of
linkage of breast cancer to the putative BRCA3 locus on chromosome
13q21 in 128 multiple case families from the Breast Cancer
Linkage Consortium. Proc Natl Acad Sci U S A. (2002)99(2):827-
31.
[31] Twardella D., Chang-Claude J. Studies on radiosensitivity
from an epidemiological point of view - overview of methods and
results. Radiotherapy Oncology (2002) 62(3):249-60.
[32] Wang-Gohrke S.*, Becher H.*, Kreienberg R.*, Runnebaum
I.B.*, Chang-Claude J. Intron 3 16 bp duplication polymorphism
of p53 is associated with an increased risk for breast cancer by
the age of 50 years. Pharmacogenetics (2002) 12(3):269-272.
[33] Altenburg H.P, Agudo A.*, Berrino F.*, Boshuizen H.C.*,
Bueno-de-Mesquita H.B.*, Janzon L.*, Le Marchand L.*,
Linseisen J., Lukanova A.*, Rasmuson T.*, Vineis P.*, Riboli E.*,
Miller A. Using multiple imputation methods to estimate relative
risks in small EPIC lung cancer subsets. In Riboli E and Lambert R
(eds). Nutrition and lifestyle: Opportunities for cancer prevention.
IARC Scientific Publications No. 156, Lyon, IARC Press,
2002, pp53-54.
[34] Becker N. Epidemiologie. in: Höffken K., Kolb G., Wedding U.
Geriatrische Onkologie. Springer, Heidelberg Berlin 2002: 3-28.
[35] Becker N. Prävalenz und Früherkennung maligner Tumoren.
In: Margulies A., Fellinger K., Kroner Th., Gaisser A. Onkologische
Krankenpflege. Springer, Berlin Heidelberg 2002.
[36] Becker N. Wissenschaftliche Nutzung von Krebsregisterdaten.
Der Onkologe (2002) 8: 26-31.
[37] Becker N. Follow-up-Studien in Deutschland: Erfahrungsbericht
unter dem Gesichtspunkt der datenschutzrechtlichen
Rahmenbedingungen. Informatik, Biometrie und Epidemiologie in
Medizin und Biologie (2002) 33: 36-44.
[38] Becker N., Nieters A., Windeler J. Tumorepidemiologie. Der
Onkologe (2002) 8 Suppl. 1: S56-S58.
[39] Boshuizen, H.C.*, Bueno-deMesquita, H.B.*, Altenburg, H.-
P., Agudo, A.*, Le Marchand, L.*, Berrino, F.*, Janzon, L.*,
Rasmuson, T.*, Vineis, P.*, Lukanova, A.*, Miller, A. Adjustment
for smoking in lung cancer analyses in the EPIC cohort. In: Nutrition
and Lifestyle: Opportunities for Cancer Prevention. IARC
scientific publications No 156, 2002:59-61.
[40] Linseisen J, Kesse E.*, Slimani N.*: Meat consumption in Europe
– results from the EPIC study. In: Nutrition and Lifestyle:
Opportunities for Cancer Prevention. IARC scientific publications
No 156, 2002: 211-212.